Home » Topics » BioWorld

BioWorld
RSS

AHP, ONCOGENE DEAL FOR GENE TRANSCRIPTION

Jan. 3, 1992

BIOTECH STOCKS STAR ON WALL ST.

Jan. 2, 1992

THE YEAR AHEAD: NIH DIRECTOR MEANS BUSINESS

Dec. 31, 1991

NOVA FILES IND FOR ANTI-INFLAMMATORY

Dec. 31, 1991

INTERNEURON DENIES DRUG TOXICITY

Dec. 31, 1991

THE YEAR AHEAD: BIOTECH LEGISLATION

Dec. 30, 1991

APPOINTMENTS AND ADVANCEMENTS

Dec. 30, 1991

SYNERGEN, XOMA STOCK UP

Dec. 30, 1991

CDC FINALIZES VACCINATION RECOMMENDATION

Dec. 30, 1991

CROP, DU PONT SIGN DEAL FOR INSECTICIDES

Dec. 30, 1991

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.